Key Record Dates
ClinicalTrials.gov Identifier: | NCT02872116 |
---|---|
Brief Title: | Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer (CheckMate649) |
First Submitted : | August 16, 2016 |
First Submitted that Met QC Criteria : | August 18, 2016 |
First Posted : | August 19, 2016 (Estimate) |
Results First Submitted : | May 18, 2022 |
Results First Submitted that Met QC Criteria : | June 23, 2022 |
Results First Posted : | June 28, 2022 |
Certification/Extension First Submitted : | May 26, 2021 |
Certification/Extension First Submitted that Met QC Criteria : | May 27, 2021 |
Certification/Extension First Posted : | June 1, 2021 |
Last Update Submitted that Met QC Criteria : | November 30, 2023 |
Last Update Posted : | December 4, 2023 |